Characterization of the Self-Resistance Mechanism to Dityromycin in the Streptomyces Producer Strain

Iron-Induced Respiration Promotes Antibiotic Resistance in Actinomycete Bacteria

The bacterial response to antibiotics eliciting resistance is one of the key challenges in global health. Despite many attempts to understand intrinsic antibiotic resistance, many of the underlying mechanisms still remain elusive. In this study, we found that iron supplementation promoted antibiotic resistance in Streptomyces coelicolor. Iron-promoted resistance occurred specifically against bactericidal antibiotics, irrespective of the primary target of antibiotics. Transcriptome profiling revealed that some genes in the central metabolism and respiration were upregulated under iron-replete conditions. Iron supported the growth of S. coelicolor even under anaerobic conditions. In the presence of potassium cyanide, which reduces aerobic respiration of cells, iron still promoted respiration and antibiotic resistance. This suggests the involvement of a KCN-insensitive type of respiration in the iron effect. This phenomenon was also observed in another actinobacterium, Mycobacterium smegmatis. Taken together, these findings provide insight into a bacterial resistance strategy that mitigates the activity of bactericidal antibiotics whose efficacy accompanies oxidative damage by switching the respiration mode.

Proteomic mechanisms for the regulation of growth, photosynthetic activity and nitrogen fixation in Nostoc sp. PCC 7120 exposed to three antibiotic contaminants

This study investigated the influences of three frequently detected antibiotics in surface waters, ciprofloxacin, tetracycline and sulfamethoxazole, on the growth, photosynthetic activity, nitrogen-fixing capacity and proteomic expression profiles of Nostoc sp. PCC 7120, through a 15-day exposure test at environmentally relevant exposure doses of 50-200 ng/L. Cyanobacterial growth was stimulated by 100 ng/L and 200 ng/L of ciprofloxacin and sulfamethoxazole as well as 50-200 ng/L of tetracycline. The nitrogenase synthesis ability in each cyanobacterial cell was stimulated by 50-200 ng/L of ciprofloxacin while inhibited by 100 ng/L and 200 ng/L of tetracycline and sulfamethoxazole. At the exposure dose of 100 ng/L for each antibiotic, the variation of total nitrogen in the culture medium indicated that the nitrogen-fixing capacity of Nostoc sp. was determined by total nitrogenase concentration calculated by cell density × nitrogenase synthesis ability. Therefore, ciprofloxacin enhanced nitrogen fixation through the stimulation of both cyanobacterial growth and nitrogenase synthesis, while tetracycline and sulfamethoxazole enhanced nitrogen fixation merely through growth stimulation. At the exposure dose of 100 ng/L, only two downregulated proteins, a phosphonate ABC transporter and a methionine aminopeptidase, as well as one upregulated protein, the phenylalanine-tRNA ligase alpha subunit, were commonly shared by three antibiotic-treated groups. Ciprofloxacin upregulated proteins related to nitrogen fixation, carbon catabolism and biosynthesis, but downregulated photosynthesis-related proteins. In contrast, tetracycline and sulfamethoxazole increased the photosynthetic activity of Nostoc sp. through upregulating photosynthesis-related proteins, but downregulated proteins related to nitrogen fixation, carbon catabolism and biosynthesis. The resistance of Nostoc sp. PCC 7120 to three target antibiotics were related with the responses of RNA synthesis regulatory proteins. Stimulation of cyanobacterial nitrogen fixation by antibiotic contaminants could aggravate eutrophication in aquatic environments.

Country Income Is Only One of the Tiles: The Global Journey of Antimicrobial Resistance among Humans, Animals, and Environment

Antimicrobial resistance (AMR) is one of the most complex global health challenges today: decades of overuse and misuse in human medicine, animal health, agriculture, and dispersion into the environment have produced the dire consequence of infections to become progressively untreatable. Infection control and prevention (IPC) procedures, the reduction of overuse, and the misuse of antimicrobials in human and veterinary medicine are the cornerstones required to prevent the spreading of resistant bacteria. Purified drinking water and strongly improved sanitation even in remote areas would prevent the pollution from inadequate treatment of industrial, residential, and farm waste, as all these situations are expanding the resistome in the environment. The One Health concept addresses the interconnected relationships between human, animal, and environmental health as a whole: several countries and international agencies have now included a One Health Approach within their action plans to address AMR. Improved antimicrobial usage, coupled with regulation and policy, as well as integrated surveillance, infection control and prevention, along with antimicrobial stewardship, sanitation, and animal husbandry should all be integrated parts of any new action plan targeted to tackle AMR on the Earth. Since AMR is found in bacteria from humans, animals, and in the environment, we briefly summarize herein the current concepts of One Health as a global challenge to enable the continued use of antibiotics.

Circumventing antimicrobial-resistance and preventing its development in novel, bacterial infection-control strategies

INTRODUCTION

Development of new antimicrobials with ever 'better' bacterial killing has long been considered the appropriate response to the growing threat of antimicrobial-resistant infections. However, the time-period between the introduction of a new antibiotic and the appearance of resistance amongst bacterial pathogens is getting shorter and shorter. This suggests that alternative pathways than making ever 'better' antimicrobials should be taken.

AREAS COVERED

This review aims to answer the questions (1) whether we have means to circumvent existing antibiotic-resistance mechanisms, (2) whether we can revert existing antibiotic-resistance, (3) how we can prevent the development of antimicrobial-resistance against novel infection-control strategies, including nano-antimicrobials.

EXPERT OPINION

Relying on relieving antibiotic-pressure and natural outcompeting of antimicrobial-resistant bacteria seems an uncertain way out of the antibiotic-crisis facing us. Novel, non-antibiotic, nanotechnology-based infection control-strategies are promising. At the same time, rapid development of new resistance mechanisms once novel strategies is taken into global clinical use, may not be ruled out and must be closely monitored. This suggests focusing research and development on designing suitable combinations of existing antibiotics with new nano-antimicrobials in a way that induction of new antimicrobial-resistance mechanisms is avoided. The latter suggestion, however, requires a change of focus in research and development.